Clinical Trials Logo

Clinical Trial Summary

Fatty liver is the most frequent chronic liver disease worldwide and ultrasonography is widely employed for diagnosis. The accuracy of this technique, however, is strongly operator-dependent. Few information is available, so far, on the possible use of algorithms based on Artificial Intelligence (AI) to ameliorate the diagnostic accuracy of ultrasonography in diagnosing fatty liver. This study showed that the use of AI is able to improve the diagnostic accuracy of ultrasonography in the diagnosis of fatty liver


Clinical Trial Description

In recent years, ultrasound has taken on a predominant role in the evaluation of liver steatosis, as it is a non-invasive, non-irradiating method that is easily reproducible and inexpensive. Of particular effectiveness is the use of the hepatorenal index, evaluated as the intensity ratio (echogenicity) between the hepatic parenchyma and the renal cortical parenchyma. The main limitations of detecting the hepato-renal index during abdominal ultrasound, however, are operator dependence and the use of a relatively long time span to complete the sequence of operations and calculations required to determine the index itself. The use of Artificial Intelligence (AI) techniques for image analysis in the medical field is yielding excellent results. AI-based algorithms are increasingly a powerful tool that allows the physician to improve their performance in terms of speed and accuracy of clinical evaluations. Today, there is already evidence of the effectiveness of using AI on ultrasound images for clinical evaluations. The use of AI as an aid in diagnosing liver diseases through ultrasound is still under-researched. The hypothesis to be tested is the utility that AI can have in the evaluation, its general and specific uses in reducing calculation times of the hepatorenal index. In this study, 134 patients were enrolled with no clinical suspicion of liver steatosis. All patients underwent abdominal ultrasonography (US) and magnetic resonance imaging fat fraction (MRI-PDFF), assumed as reference technique to evaluate the grade of steatosis. The hepatorenal index (US) was manually calculated (HRIM) by 4 skilled operators. An automatic hepatorenal index calculation (HRIA) was also obtained by an algorithm. The accuracy of HRIA to discriminate different grades of fatty liver was evaluated by Receiver operating characteristic (ROC) analysis using MRI-PDFF cut-offs. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06103175
Study type Observational
Source University of Bari
Contact
Status Active, not recruiting
Phase
Start date January 15, 2023
Completion date November 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03542578 - Diagnosis of Fatty Liver With Outpatient Ultrasound
Active, not recruiting NCT04682600 - The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF N/A
Completed NCT06443723 - Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy Patients N/A
Not yet recruiting NCT05884723 - Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis N/A
Not yet recruiting NCT05790057 - Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )
Completed NCT04579874 - Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. N/A
Completed NCT05224037 - Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch N/A
Recruiting NCT06111859 - Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification N/A
Recruiting NCT03699228 - China Health Big Data
Completed NCT03342703 - Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI